Brief: Hebang Biotechnology's Unit Signs Agreement To Invest In Avenira Limited
Dec 4 (Reuters) - Sichuan Hebang Biotechnology
603077.SS :
* SAYS AS OF NOV 30, IT HAS BOUGHT BACK CO SHARES WORTH
356.8
MILLION YUAN ($50.00 million)
* SAYS UNIT SIGNS AGREEMENT TO INVEST IN AVENIRA LIMITED FOR
A$2.0
MILLION ($1.33 million)
* SAYS IT WILL OWN 12.04% STAKE IN AVENIRA LIMITED AFTER
TRANSACTION
Source text
Source text 2
Further company coverage: 603077.SS
($1 = 7.1364 Chinese yuan renminbi)
($1 = 1.5038 Australian dollars)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Avenira
See all newsAustralia's Avenira jumps most in more than 6 years on project development financing
Brief: Avenira Enters Facility Arrangements With Hebang For Up To A$85 Million
Australia's Avenira falls on discounted capital raising
Brief: Avenira Announces Renounceable Rights Issue
Brief: Avenira Formally Approved A$2.6M Exploration Budget To Advance Jundee South Gold Project